tirzepatide and menstruation Shed GLP-1 medications like semaglutide and

Retatrutide, by contrast, acts directly on incretin and glucagon receptors

A proper review should include medical history, medications, possible contraindications, expected side effects, dosing strategy, activity limitations, and whether any baseline labs or monitoring are appropriate

These symptoms may indicate serious conditions such as pancreatitis, gallbladder disease, or dehydration leading to acute kidney injury, which have been associated with the GLP-1 receptor agonist class and require prompt clinical review

And I started taking Mounjaro

Josh Lindsley, DO, DABOM Frequently Asked Questions Clinical trials show tirzepatide produces greater average weight loss (up to 22.5%) compared to semaglutide (15%)